Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
Fernández-Montequín JI, Infante-Cristiá E, Valenzuela-Silva C, Franco-Pérez N, Savigne-Gutierrez W, Artaza-Sanz H, Morejón-Vega L, González-Benavides C, Eliseo-Musenden O, García-Iglesias E, Berlanga-Acosta J, Silva-Rodríguez R, Betancourt BY, López-Saura PA; Cuban Citoprot-P Study Group. Fernández-Montequín JI, et al. Int Wound J. 2007 Dec;4(4):333-43. doi: 10.1111/j.1742-481X.2007.00344.x. Epub 2007 Oct 22. Int Wound J. 2007. PMID: 17953679 Free PMC article. Clinical Trial.
Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study.
Fernández-Montequín JI, Valenzuela-Silva CM, Díaz OG, Savigne W, Sancho-Soutelo N, Rivero-Fernández F, Sánchez-Penton P, Morejón-Vega L, Artaza-Sanz H, García-Herrera A, González-Benavides C, Hernández-Cañete CM, Vázquez-Proenza A, Berlanga-Acosta J, López-Saura PA; Cuban Diabetic Foot Study Group. Fernández-Montequín JI, et al. Int Wound J. 2009 Dec;6(6):432-43. doi: 10.1111/j.1742-481X.2009.00641.x. Int Wound J. 2009. PMID: 20051095 Free PMC article. Clinical Trial.
Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers.
Yera-Alos IB, Alonso-Carbonell L, Valenzuela-Silva CM, Tuero-Iglesias AD, Moreira-Martínez M, Marrero-Rodríguez I, López-Mola E, López-Saura PA. Yera-Alos IB, et al. Among authors: lopez saura pa. BMC Pharmacol Toxicol. 2013 Sep 3;14:44. doi: 10.1186/2050-6511-14-44. BMC Pharmacol Toxicol. 2013. PMID: 24004460 Free PMC article.
C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
Pentón-Rol G, Martínez-Sánchez G, Cervantes-Llanos M, Lagumersindez-Denis N, Acosta-Medina EF, Falcón-Cama V, Alonso-Ramírez R, Valenzuela-Silva C, Rodríguez-Jiménez E, Llópiz-Arzuaga A, Marín-Prida J, López-Saura PA, Guillén-Nieto GE, Pentón-Arias E. Pentón-Rol G, et al. Int Immunopharmacol. 2011 Jan;11(1):29-38. doi: 10.1016/j.intimp.2010.10.001. Epub 2010 Oct 23. Int Immunopharmacol. 2011. PMID: 20971186
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
Betancourt BY, Marrero-Miragaya MA, Jiménez-López G, Valenzuela-Silva C, García-Iglesias E, Hernández-Bernal F, Debesa-García F, González-López T, Alvarez-Falcón L, López-Saura PA; Cuban National Network of Pharmacoepidemiology. Betancourt BY, et al. BMC Clin Pharmacol. 2005 Nov 2;5:5. doi: 10.1186/1472-6904-5-5. BMC Clin Pharmacol. 2005. PMID: 16262910 Free PMC article.
C-Phycocyanin is neuroprotective against global cerebral ischemia/reperfusion injury in gerbils.
Pentón-Rol G, Marín-Prida J, Pardo-Andreu G, Martínez-Sánchez G, Acosta-Medina EF, Valdivia-Acosta A, Lagumersindez-Denis N, Rodríguez-Jiménez E, Llópiz-Arzuaga A, López-Saura PA, Guillén-Nieto G, Pentón-Arias E. Pentón-Rol G, et al. Among authors: lopez saura pa. Brain Res Bull. 2011 Aug 10;86(1-2):42-52. doi: 10.1016/j.brainresbull.2011.05.016. Epub 2011 Jun 6. Brain Res Bull. 2011. PMID: 21669260
71 results